Keep current on the latest news from Allegro Ophthalmics

Sign up today to be notified about the initiation of clinical trials, study results and breaking company news.

Your info will never be shared with a third-party

No Thanks
×

“New Study Affirms Promise of Anti-Integrin Drug for DME”

December 09, 2016

A new class of ophthalmic drug continues to show promise for treating patients with diabetic macular edema (DME).

To read the article, please visit Ophthalmology Times“New Study Affirms Promise of Anti-Integrin Drug for DME”